LJ Rubin

922 total citations · 1 hit paper
6 papers, 653 citations indexed

About

LJ Rubin is a scholar working on Pulmonary and Respiratory Medicine, Pathology and Forensic Medicine and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, LJ Rubin has authored 6 papers receiving a total of 653 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Pulmonary and Respiratory Medicine, 1 paper in Pathology and Forensic Medicine and 1 paper in Cardiology and Cardiovascular Medicine. Recurrent topics in LJ Rubin's work include Pulmonary Hypertension Research and Treatments (6 papers), Liver Disease and Transplantation (1 paper) and Systemic Sclerosis and Related Diseases (1 paper). LJ Rubin is often cited by papers focused on Pulmonary Hypertension Research and Treatments (6 papers), Liver Disease and Transplantation (1 paper) and Systemic Sclerosis and Related Diseases (1 paper). LJ Rubin collaborates with scholars based in United States, Switzerland and Italy. LJ Rubin's co-authors include Nazzareno Galiè, Pavel Jansa, Andjela Kusic‐Pajic, Hikmet Al‐Hiti, Marius M. Hoeper, Gérald Simonneau, Eleonora Chiossi, Hossein Ardeschir Ghofrani, Richard N. Channick and Iréne Lang and has published in prestigious journals such as The Lancet and Thorax.

In The Last Decade

LJ Rubin

5 papers receiving 625 citations

Hit Papers

Treatment of patients with mildly symptomatic pulmonary a... 2008 2026 2014 2020 2008 200 400 600
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Treatment of patients with mildly symptomatic pulmonary arterial hypertension with bosentan (EARLY study): a double-blind, randomised controlled trial
    2008 647 citations Nazzareno Galiè, LJ Rubin et al. The Lancet profile →

Peers

LJ Rubin
David Kylhammar Sweden
A. Mañes Italy
SJ Wort United Kingdom
L. Achouh France
Abby Poms United States
Juliana Liu United States
Mehmet Ata Akıl Türkiye
Xi‐Qi Xu China
Rubina Khair United States
Roela Sadushi‐Kolici Austria
David Kylhammar Sweden
LJ Rubin
Citations per year, relative to LJ Rubin LJ Rubin (= 1×) peers David Kylhammar

Countries citing papers authored by LJ Rubin

Since Specialization
Citations

This map shows the geographic impact of LJ Rubin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by LJ Rubin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites LJ Rubin more than expected).

Fields of papers citing papers by LJ Rubin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by LJ Rubin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by LJ Rubin. The network helps show where LJ Rubin may publish in the future.

Co-authorship network of co-authors of LJ Rubin

This figure shows the co-authorship network connecting the top 25 collaborators of LJ Rubin. A scholar is included among the top collaborators of LJ Rubin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with LJ Rubin. LJ Rubin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

6 of 6 papers shown
1.
2.
3.
4.
Keogh, Anne, et al.. (2009). ARIES-3: Ambrisentan Therapy in a Diverse Population of Patients with Pulmonary Hypertension.. A3357–A3357. 2 indexed citations
5.
Galiè, Nazzareno, LJ Rubin, Marius M. Hoeper, et al.. (2008). Treatment of patients with mildly symptomatic pulmonary arterial hypertension with bosentan (EARLY study): a double-blind, randomised controlled trial. The Lancet. 371(9630). 2093–2100. 647 indexed citations breakdown →
6.
Levy, Paul S., et al.. (1994). Survival in Primary Pulmonary-Hypertension with Long-Term Continuous Intravenous Prostacyclin (Vol 121, Pg 409, 1994). 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by David Kylhammar Breakdown of academic impact, for papers by A. Mañes Breakdown of academic impact, for papers by SJ Wort Breakdown of academic impact, for papers by L. Achouh Breakdown of academic impact, for papers by Abby Poms Breakdown of academic impact, for papers by Juliana Liu Breakdown of academic impact, for papers by Mehmet Ata Akıl Breakdown of academic impact, for papers by Xi‐Qi Xu Breakdown of academic impact, for papers by Rubina Khair Breakdown of academic impact, for papers by Roela Sadushi‐Kolici
Rankless by CCL
2026